FibroBiologics, Inc. Common Stock (FBLG) NASDAQ
0.20
-0.0234(-10.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.20
-0.0234(-10.64%)
Currency In USD
| Market Cap | 10.04M |
| Enterprise Value | 7.56M |
| P/E Ratio | -0.47 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.94 |
| Return On Equity | -7.86 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -832,000 |
| EBITDA | -17.61M |
| Net Income | -18.65M |
| Diluted EPS | -0.42 |
| Total Cash | 4.89M |
| Total Cash/Share | 0.11 |
| Total Debt | 2.41M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 3.61 |
| Book Value Per Share | 0.14 |
| 52-Week Change | -80.73 |
| 52-Week High | 1.53 |
| 52-Week Low | 0.19 |
| Moving Average 50 Days | 0.31 |
| Moving Average 200 Days | 0.46 |
| Average Volume | 1.69M |
| Shares Outstanding | 41.92M |
| % Held by Institutions | 10.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 30, 2026 |